There are and have been no afrezza/dreamboat results.
It did take 1400 patients to find 250 for the current trial. This is a bad sign. The 550% dilution is a decision that has ended afrezza before it could fail. This is flag to big pharma that you can't deal with crazy. Alfalfa has proven to be a block head. He won't deal, is unreasonable on his position, and now have the necessary investment needed impossible. Then last the current trial is attempting to use 30% less afrezza. Alfalfa has a snow balls chance in a Texas summer. Which is none. The is why institutional investment walked away.
The motley fool is just trying to make a fool out of you? Alfalfa Mann child just lines his pocket with shares for nothing in money. Buy at the same time wrecked any long time future. He is no the king of a body dump. He killed mnkd and afrezza has died while still on the table. Institutional investors have walked awayl this is DOA before the FDA . Never trust and old rascal. Alfalfa.
Habusa, what keeps you bashing even on weekends? Short? Or still hoping to get in at $1.90? What is your play here? I'm just glad we are on opposite sides since I don't seem to make money when we are on the same side.